Arcturus Therapeutics Holdings (ARCT) Capital Expenditures (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) posted Capital Expenditures of -$88,000 for Q4 2025.
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) Capital Expenditures (2018 - 2025) Analysis & Trends
For FY2025, Arcturus Therapeutics Holdings' Capital Expenditures came in at $230,000, down 64.5% from FY2024.
- Annual Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -33.3% (FY2020 to FY2025).
- In prior years, Arcturus Therapeutics Holdings' Capital Expenditures was $648,000 in FY2024 (-77.7%), $2.9 million in FY2023 (-62.5%), $7.73 million in FY2022 (+126.8%) and $3.41 million in FY2021 (+95.5%).
- The Q4 2025 figure stands as the lowest quarterly Capital Expenditures since Q2 2022.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last five quarters, with an average decline of 16.2%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2021, with growth of 306.9%; the weakest was Q3 2024, with a decline of 91.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Arcturus Therapeutics Holdings | 389.40 Mn | -424.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -88,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 328,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 875,000.00 |
| Sep 30, 2023 | 981,000.00 |
| Jun 30, 2023 | 354,000.00 |
| Mar 31, 2023 | 691,000.00 |
| Dec 31, 2022 | 3.81 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | -378,000.00 |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 404,000.00 |
| Mar 31, 2021 | 118,000.00 |
| Dec 31, 2020 | 697,000.00 |
| Sep 30, 2020 | 434,000.00 |
API Access
Arcturus Therapeutics Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();